HARRY WINSTON LAUNCHES COUNTDOWN TO A CURE TIMEPIECE TO BENEFIT AMFAR
International fine jeweler and watchmaker, Harry Winston, Inc., has announced the launch of the Countdown to a Cure Timepiece, in honor of its second year of partnership with amfAR, The Foundation for AIDS Research. This limited edition timepiece, of 20 men’s and 20 women’s models, is the first official product to benefit amfAR’s efforts to develop the scientific basis of a cure for HIV by 2020.
Retailing for $21,200 for the men’s timepiece, and $16,200 for the women’s, the Countdown to a Cure Timepiece will be sold exclusively at Harry Winston salons worldwide, with 20% of the retail sales price from each limited-edition timepiece benefiting amfAR.
Part of Harry Winston’s timeless Midnight Collection, the men’s version features a 42mm white gold case with a navy blue dial that is accented with a multicolor gradient, representing amfAR’s Countdown to a Cure campaign colors that symbolize the fade of the disease from crisis to cure, while the complementing 32mm women’s model is meticulously set with 12 brilliant-cut diamonds and 19 vivid gemstones, from rubies and sapphires to spessartite garnets.
“We are proud to introduce the new Countdown to a Cure Timepiece and further strengthen our commitment to amfAR,” said Nayla Hayek, CEO of Harry Winston, Inc. “Through Harry Winston’s support, amfAR has been able to make significant research investments into cutting-edge research studies that address the remaining roadblocks to a cure. It is our hope that through our continued partnership, amfAR will be able to advance its efforts to end the global HIV/AIDS epidemic, giving millions of individuals around the world a more brilliant and healthy future.”
“We are deeply grateful to our friends at Harry Winston for their partnership and support,” said Kevin Robert Frost, CEO of amfAR. “The AIDS epidemic continues to take lives with every passing minute, so the Countdown to a Cure timepiece is a fitting symbol of the urgency with which we’re pursuing our goal of a cure for HIV.”